FREE Bionics

Spun off from Taiwan’s Industrial Technology Research Institute (ITRI) in 2017, FREE Bionics has established itself as the first independent company in Taiwan developing powered exoskeletons and bionic technology products. The company’s R&D team began their work in 2012 and earned the prestigious R&D 100 Award in 2016 before formally incorporating.

Company Overview

FREE Bionics operates from Hsinchu Science Park, Taiwan’s technology hub, with a team of engineers and physiotherapists developing rehabilitation exoskeletons. The company distinguishes itself through its sensor-free approach, using AI algorithms and motor impedance sensing rather than traditional electromyography (EMG) patches to detect user intent. This eliminates common issues with skin-mounted sensors such as incorrect placement and sweat interference.

Wistron, the electronics manufacturing giant, holds a 37% stake as the largest shareholder, providing both capital and manufacturing expertise. The company has also received investment from Keihanna Global Acceleration Program and StraightWalk Fund.

Core Products

FREE Walk

The flagship lower limb exoskeleton assists patients with spinal cord injuries and lower limb weakness to stand, walk, and perform functional training. Powered motors at the hip and knee joints provide mobility support while the control system coordinates movement patterns. The device received TFDA, CE Mark, and MDSAP certifications in 2019.

NimBO

A multi-joint training robot capable of exercising all six major human joints (shoulders, elbows, wrists, hips, knees, ankles). Unlike competing products, NimBO uses proprietary algorithms to sense patient movement without external sensors attached to the body. The system provides quantitative rehabilitation assessment data, addressing the shortage of physical therapists in clinical settings.

KneeBO

A portable single-joint exoskeleton weighing only 1.5 kg, designed for individuals with knee joint deterioration or post-surgical rehabilitation. Users can don the device within one minute. The product was showcased at CES 2025 to positive reception.

HipBO

A lightweight hip joint exoskeleton under 3 kg with built-in metronome guidance for walking rhythm. Targets individuals with hip joint functional decline for daily walking and hiking assistance.

Technology & Innovation

FREE Bionics’ core technological advantage lies in its impedance-based sensing approach. When users exert muscle force, the system detects micro-resistance changes through precision motors and AI computation, instantly determining movement direction and force magnitude without requiring skin-mounted sensors. This provides more reliable operation compared to EMG-based systems that can fail due to sensor misplacement or perspiration.

The company holds certifications including ISO 13485 for quality management systems and has earned multiple industry recognitions:

• 2016 R&D 100 Award (Global Top 100 Innovations)
• 2018 China International Welfare Expo Gold Award
• 2020 Taipei Biotech Award (Innovation Technology Excellence)
• 2020 National Innovation Award (Enterprise Category)
• 2022 SNQ National Quality Mark

Market Presence

FREE Walk has been deployed in approximately one-third of Taiwan’s medical centers and is sold in 20 countries including Japan, Malaysia, and multiple European nations. The company established offices in Japan and mainland China early in its development. Over 100 medical institutions are in the process of adopting NimBO for rehabilitation services.

The data-driven exoskeleton system addresses global healthcare challenges including therapist shortages and aging populations. At MEDICA 2023 in Düsseldorf, FREE Bionics showcased its products as part of the Taiwan Smart Health pavilion, generating interest from European healthcare providers.

Key Milestones

• 2012: R&D team begins exoskeleton development at ITRI
• 2016: Receives R&D 100 Award for innovation
• 2017: Spins off from ITRI as FREE Bionics Taiwan Inc.
• 2017: Wistron becomes largest shareholder with 37% stake
• 2019: FREE Walk obtains TFDA, CE Mark, and MDSAP certifications
• 2023: Participates in MEDICA trade fair in Germany
• 2025: KneeBO and HipBO debut at CES 2025

Frequently Asked Questions

What conditions can FREE Bionics products treat?

FREE Walk assists patients with spinal cord injuries and lower limb paralysis. NimBO serves patients with sarcopenia, degenerative arthritis, and post-orthopedic surgery rehabilitation. KneeBO and HipBO target sub-healthy elderly populations with joint function decline.

Is FREE Bionics publicly traded?

No, FREE Bionics remains a private company. Wistron Corporation (3231.TW) holds a 37% stake as the largest shareholder.

Where are FREE Bionics products available?

Products are available in Taiwan, Japan, China, Malaysia, and approximately 20 countries including multiple European nations. The company provides both sales and rental options in Taiwan.

What certifications do FREE Bionics products have?

FREE Walk has obtained TFDA (Taiwan), CE Mark (EU), MDSAP, and reportedly FDA clearance. The company maintains ISO 13485 quality management certification.